Most common AEs: nausea, diarrhea, vomiting, constipation mostly mild-to-moderate Onset: events concentrated during the 20-week titration period Discontinuation due to AEs: 4.3% (5 mg), 7.1% (10 mg), 6.2% (15 mg) vs 2.6% placebo Serious AEs: similar incidence across tirzepatide and placebo groups New signals: none identified beyond the known GLP-1 / GIP class profile Clinical significance Why SURMOUNT-1 reset the field Three observations stood out when SURMOUNT-1 was published in NEJM in 2022, and they still shape how Dr
Tradeindia Common Medicines & Drugs L Carnitine In Stock Product Specifications Product Overview Key Features This medication is a diet supplement used to prevent and treat low blood levels of carnitine
Because ORLISTAT can interfere with the absorption of fat-soluble vitamins, all patients should take a daily multivitamin that contains vitamins A, D, E, K, and beta-carotene
Don and I liked Sarahs point about nutrition with this